TREATMENT OF PARKINSON WHITE SYNDROME WOLFF
The Wolff Parkinson White syndrome is a rare heart disease that includesin preexcitation syndromes can present with characteristic ECG and cardiac arrhythmias.
Search for information in different libraries and newspaper archives as well as sites by examining the clinical diagnostic ancillary studies, trying to differentiate between different types of patients at low or high stratifying risk to determine what treatment is advised in each case and the benefits and disadvantages of each.
Wolf Parkinson White syndrome, arrhythmias, radiofrequency ablation The Wolff Parkinson White syndrome is an infrecuent That is cardiac disease include Between the
preexcitation syndrome and is Characterized by arrhythmia and characteristic electrocardiogram.
We search for information in librarys, articles in magazines and internet, studying the Manifestations and complementary diagnostic clinical studies, Trying to make a Difference Between Them Several Patients and classify in high an low for the insaturation Risk of Corret Treatment in Each case.
INTRODUCTION
WOLFF PARKINSON syndrome
White (WPW) is the most common of the preexcitation syndromes was studied by
Drs Louis Wolf, John Parkinson and Paul
Dudley White in 1930
(1)
It is a congenital heart abnormality
is the presence of an anomalous beam
(Bundle of Kent) that bypasses the normal system
directly connecting atria and conduction
ventricles. In this syndrome in which the ventricles are activated, in addition to the atrioventricular node (NAV) by an anomalous pathway
driving faster than the normal driving system
(2).
The prevalence of
This syndrome is between 0.1 and 0.3% in the
general population
(3),
with an incidence of 2-1 in
men to women
(2).
95% of cases no associated heart disease but may do to other
congenital abnormalities such as disease
Ebstein, mitral valve prolapse, tuberous sclerosis, Brugada syndrome
(4),
and the rare
association with agenesis of the inferior vena cava
(5).
It can affect patients of all
ages from fetuses and infants up to
the elderly and also
identical twins
(6)
, 80 -90% of cases are detected in children under 50 years
(2).
The risk of sudden death from this disease
is 0.6 - 1.5%. 25% of them occur as a first manifestation of the syndrome. In young people the risk is 3.6%
appearing as the first manifestation in
40% of cases
(1).
The syndrome may occur as
isolated or appear in both members of a
same family, the latter form of presentation is called familial or inherited.
It is an autosomal dominant disorder
7q34-q36 gene coding for the subunit
Activated protein kinase cyclic amp (PRKAG2)
where the mutation is the substitution resulting
glutamine for arginine at residue 302,
protein
(7).
Objectives: The aim of this review
literature consists in selecting patients with WPW syndrome that
are candidates for drug treatment
or radiofrequency catheter ablation
, Highlighting the most effective treatment, safe
convenient and cost benefit
each patient.
Comments
Post a Comment